Challenges in Adjuvant Immunotherapy after Resection or Ablation for High-Risk Hepatocellular Carcinoma at High-Risk of Recurrence

Challenges in Adjuvant Immunotherapy after Resection or Ablation for High-Risk Hepatocellular Carcinoma at High-Risk of Recurrence

Saved in:

Bibliographic Details
Main Author:	Masatoshi Kudo
Format:	Article
Language:	English
Published:	Karger Publishers 2024-10-01
Series:	Liver Cancer
Online Access:	https://beta.karger.com/Article/FullText/542221
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
by: Yasunori Minami, et al.
Published: (2011-01-01)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
by: Kirti Shetty, et al.
Published: (2014-01-01)

Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety
by: Wang Junxiao, et al.
Published: (2024-12-01)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
by: Hui Ma, et al.
Published: (2021-01-01)

Risk factors for residual liver recurrence of colorectal cancer after resection of liver metastases and significance of adjuvant chemotherapy
by: Hiroko Sawano, et al.
Published: (2024-12-01)

Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma
by: Chao Li, et al.
Published: (2023-08-01)

Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
by: Jiahao Li, et al.
Published: (2024-11-01)

Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
by: Gui-Lin Xie, et al.
Published: (2025-01-01)

Prognostic factors for hepatocellular carcinoma recurrence after liver transplantation or resection – single-center experience
by: Maciej Gryziak, et al.
Published: (2024-11-01)

Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin
by: Jinyu Zhang, et al.
Published: (2024-11-01)

Surgical resection versus thermal ablation: comparison of sequential options after successful TACE downstaging therapy for unresectable hepatocellular carcinoma
by: Chao An, et al.
Published: (2025-01-01)

Laser Ablation for Small Hepatocellular Carcinoma
by: Claudio Maurizio Pacella, et al.
Published: (2011-01-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Highly efficient polyethylene glycol‐functionalised gold nanorods for photothermal ablation of hepatocellular carcinoma cells
by: Xingyu Du, et al.
Published: (2019-10-01)

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
by: Zhang G, et al.
Published: (2025-01-01)

Three-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma in Patients Unfit for Resection, Ablation, or Chemotherapy: A Retrospective Study
by: Vassilis Kouloulias, et al.
Published: (2013-01-01)

Comparison of the long‐term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
by: Ning‐Ning Zhang, et al.
Published: (2023-02-01)

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
by: Yu ZC, et al.
Published: (2025-01-01)

A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma
by: Jun Wang, et al.
Published: (2013-01-01)

Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis
by: Gonghao Li, et al.
Published: (2025-01-01)

Surgical resection versus thermal ablation after intra-arterial conversion therapy for unresectable hepatocellular carcinoma: a multicenter retrospective one as per the STROBE guidelines
by: Yusen Du, et al.
Published: (2024-12-01)

Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience
by: I. Csányi, et al.
Published: (2024-01-01)

Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
by: Young Mi Hong
Published: (2024-12-01)

Laparoscopic liver resection versus radiofrequency ablation for hepatocellular carcinoma within Milan criteria: a meta-analysis and systematic review
by: Lin Xu, et al.
Published: (2024-11-01)

Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study
by: Sainan Guan, et al.
Published: (2024-12-01)

Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment
by: Xuexia Liang, et al.
Published: (2024-12-01)

Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
by: Qi Fan, MM, et al.
Published: (2025-01-01)

Risk factors of development of hepatocellular carcinoma
by: V. T. Ivashkin, et al.
Published: (2009-02-01)

Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates
by: Xihao Xie, et al.
Published: (2024-12-01)

Lack of Adjuvant Radiotherapy May Increase Risk of Retropharyngeal Node Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck after Transoral Robotic Surgery
by: Waleed F. Mourad, et al.
Published: (2013-01-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
by: Chen Shen, et al.
Published: (2025-01-01)

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
by: Wei Chen, et al.
Published: (2025-01-01)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
by: Kyunghye Bang, et al.
Published: (2023-02-01)

Factors Associated with Recurrence of Varicose Veins after Thermal Ablation: Results of The Recurrent Veins after Thermal Ablation Study
by: R. G. Bush, et al.
Published: (2014-01-01)

Immunity revealed: Stratifying hepatocellular carcinoma for precision immunotherapy
by: Konstantinos Arvanitakis, et al.
Published: (2025-03-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
by: Yingjun Xie, et al.
Published: (2018-01-01)

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01)

Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01)